Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database Academic Article uri icon

Overview

MeSH Major

  • Stomach Neoplasms

abstract

  • The current population-based observational study suggested a potential survival benefit for adjuvant RT among patients with diffuse-type gastric cancer. The standard treatment will likely remain controversial until evidence becomes available from phase 3 randomized trials exclusively for patients with diffuse-type gastric cancer.

publication date

  • November 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.28913

PubMed ID

  • 25043858

Additional Document Info

start page

  • 3562

end page

  • 8

volume

  • 120

number

  • 22